[O2-2] Flavi/Hepaci/Togavirus

[O2-2-16] Development of therapeutic molecules across Blood-Brain Barrier for treatment of TBE

*Mizuki Fukuta^1,2,3, Sayo Fukano⁴, Shintaro Kobayashi⁴, Naoya Maekawa⁵, Yuji Takahashi⁴, Minato Hirano^2,3, Hiroaki Kariwa⁴, Satoru Konnai^5,6, Kentaro Yoshii^2,3,4 (1. Nagasaki University Graduate School of Biomedical Sciences, 2. National Research Center for the Control and Prevention of Infectious Diseases, Nagasaki University, 3. Institute of Tropical Medicine, Nagasaki University, 4. Laboratory of Public Health, Faculty of Veterinary Medicine, Hokkaido University, 5. Department of Advanced Pharmaceutics, Faculty of Veterinary Medicine, Hokkaido University, 6. Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University)